
Big Pharma gravy train hits the skids under Trump, panicking revolving-door regulators, investors
The Food and Drug Administration is "finished." One of its leading boosters for accelerated approval of mediocre drugs left in a huff. Drug stocks are dropping. The shared interests of regulators and the industry they often join after or between …